ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645431 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645431; 2) Community: the network communities that were significantly associated with the response to NSC 645431; 3) Molecule: the relationships between components within communities and NSC 645431; 4) MDR: the compounds that were significantly associated with the NSC 645431.

NSC Compound Enrichment Correlation
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0244632509325736 0.16211623
NSC 606498 Camptothecin Derivative 0.0244632509325736 0.17069277
NSC 609699 Topotecan hydrochloride 0.0244632509325736 0.17145659
NSC 610458 Camptothecin Derivative 0.0244632509325736 0.12724021
NSC 624474 Null 0.0244632509325736 -0.2205638
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.0244632509325736 0.38568532
NSC 644960 Null 0.0244632509325736 0.096630514
NSC 672073 Null 0.0244632509325736 0.21092158
NSC 682821 Propanimidoyl chloride, 2-methyl-N-[[[(3-methylphenyl) amino]carbonyl]oxy]- 0.0244632509325736 0.27914055
NSC 698057 Null 0.0244632509325736 0.19017399
Total:61  Current:32    [First] [Prev] [Next] [Last]